On the public citation graph

High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection

https://doi.org/10.1128/jvi.00871-13
0 signed · 153 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1016/j.chom.2010.08.007openalex-snapshot
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
inferredcites →https://doi.org/10.1016/j.jcv.2007.04.005openalex-snapshot
Sensitivity and specificity of three ELISA-based assays for discriminating primary from secondary acute dengue virus infection
inferredcites →https://doi.org/10.1016/j.virol.2007.05.042openalex-snapshot
Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus
inferredcites →https://doi.org/10.1016/j.virol.2009.06.037openalex-snapshot
Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
inferredcites →https://doi.org/10.1016/s0092-8674(02)00660-8openalex-snapshot
Structure of Dengue Virus
inferredcites →https://doi.org/10.1016/s0140-6736(12)61428-7openalex-snapshot
Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
inferredcites →https://doi.org/10.1016/s1473-3099(09)70254-3openalex-snapshot
Progress towards a dengue vaccine
inferredcites →https://doi.org/10.1038/265739a0openalex-snapshot
Antibody-enhanced dengue virus infection in primate leukocytes
inferredcites →https://doi.org/10.1038/nature02165openalex-snapshot
Structure of the dengue virus envelope protein after membrane fusion
inferredcites →https://doi.org/10.1038/nm.2997openalex-snapshot
Defeating dengue: a challenge for a vaccine
inferredcites →https://doi.org/10.1038/nm887openalex-snapshot
Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever
inferredcites →https://doi.org/10.1038/nprot.2009.3openalex-snapshot
Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen
inferredcites →https://doi.org/10.1038/nrmicro2460openalex-snapshot
Dengue: a continuing global threat
inferredcites →https://doi.org/10.1073/pnas.1010867107openalex-snapshot
Immunodominant T-cell responses to dengue virus NS3 are associated with DHF
inferredcites →https://doi.org/10.1073/pnas.1200566109openalex-snapshot
Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
inferredcites →https://doi.org/10.1073/pnas.1304300110openalex-snapshot
Dengue structure differs at the temperatures of its human and mosquito hosts
inferredcites →https://doi.org/10.1073/pnas.1305227110openalex-snapshot
Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8 + T cells
inferredcites →https://doi.org/10.1093/infdis/128.1.7openalex-snapshot
Studies on the Pathogenesis of Dengue Infection in Monkeys. I. Clinical Laboratory Responses to Primary Infection
inferredcites →https://doi.org/10.1093/infdis/jir607openalex-snapshot
B-Cell Responses During Primary and Secondary Dengue Virus Infections in Humans
inferredcites →https://doi.org/10.1093/oxfordjournals.aje.a121372openalex-snapshot
CROSS-PROTECTION STUDIES AND SEARCH FOR SUBCLINICAL DISEASE IN NEW WORLD MONKEYS INFECTED SEQUENTIALLY WITH DIFFERENT IMMUNOLOGIC TYPES OF DENGUE VIRUSES1
inferredcites →https://doi.org/10.1099/0022-1317-70-1-37openalex-snapshot
Antigenic Relationships between Flaviviruses as Determined by Cross-neutralization Tests with Polyclonal Antisera
inferredcites →https://doi.org/10.1099/0022-1317-71-8-1845openalex-snapshot
Low pH-induced Cell Fusion in Flavivirus-infected Aedes Albopictus Cell Cultures
inferredcites →https://doi.org/10.1099/vir.0.012120-0openalex-snapshot
N-Linked glycans on dengue viruses grown in mammalian and insect cells
inferredcites →https://doi.org/10.1099/vir.0.82210-0openalex-snapshot
Flavivirus membrane fusion
inferredcites →https://doi.org/10.1111/j.1600-065x.2008.00676.xopenalex-snapshot
The structural immunology of antibody protection against West Nile virus
inferredcites →https://doi.org/10.1111/j.1600-065x.2010.00938.xopenalex-snapshot
Memory B and memory plasma cells
inferredcites →https://doi.org/10.1126/science.1185181openalex-snapshot
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
inferredcites →https://doi.org/10.1126/science.3277268openalex-snapshot
Pathogenesis of Dengue: Challenges to Molecular Biology
inferredcites →https://doi.org/10.1126/scitranslmed.3003888openalex-snapshot
The Structural Basis for Serotype-Specific Neutralization of Dengue Virus by a Human Antibody
inferredcites →https://doi.org/10.1128/jvi.00286-09openalex-snapshot
Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step
inferredcites →https://doi.org/10.1128/jvi.00291-08openalex-snapshot
Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo
inferredcites →https://doi.org/10.1128/jvi.00316-08openalex-snapshot
Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II
inferredcites →https://doi.org/10.1128/jvi.00432-07openalex-snapshot
Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes
inferredcites →https://doi.org/10.1128/jvi.00757-13openalex-snapshot
Structural Changes in Dengue Virus When Exposed to a Temperature of 37°C
inferredcites →https://doi.org/10.1128/jvi.01190-10openalex-snapshot
Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
inferredcites →https://doi.org/10.1128/jvi.02298-12openalex-snapshot
An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection
inferredcites →https://doi.org/10.1128/jvi.06075-11openalex-snapshot
Rapid and Massive Virus-Specific Plasmablast Responses during Acute Dengue Virus Infection in Humans
inferredcites →https://doi.org/10.1128/jvi.06335-11openalex-snapshot
Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection
inferredcites →https://doi.org/10.1128/jvi.75.16.7769-7773.2001openalex-snapshot
Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells
inferredcites →https://doi.org/10.1146/annurev-immunol-031210-101315openalex-snapshot
Immune Response to Dengue Virus and Prospects for a Vaccine
inferredcites →https://doi.org/10.1186/1743-422x-7-28openalex-snapshot
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
inferredcites →https://doi.org/10.1186/1743-422x-9-115openalex-snapshot
Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement
inferredcites →https://doi.org/10.1371/journal.pntd.0001188openalex-snapshot
In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
inferredcites →https://doi.org/10.1371/journal.pntd.0001447openalex-snapshot
Analysis of Epitopes on Dengue Virus Envelope Protein Recognized by Monoclonal Antibodies and Polyclonal Human Sera by a High Throughput Assay
inferredcites →https://doi.org/10.1371/journal.pntd.0001568openalex-snapshot
Dominant Cross-Reactive B Cell Response during Secondary Acute Dengue Virus Infection in Humans
inferredcites →https://doi.org/10.1371/journal.pone.0004991openalex-snapshot
Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens
inferredcites →https://doi.org/10.1371/journal.ppat.1000453openalex-snapshot
A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes
inferredcites →https://doi.org/10.1371/journal.ppat.1000823openalex-snapshot
The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
inferredcites →https://doi.org/10.1371/journal.ppat.1002111openalex-snapshot
A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus
inferredcites →https://doi.org/10.1371/journal.ppat.1003157openalex-snapshot
Therapeutic Efficacy of Antibodies Lacking FcγR against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies
inferredcites →https://doi.org/10.3389/fimmu.2012.00334openalex-snapshot
Sculpting humoral immunity through dengue vaccination to enhance protective immunity
inferredcites →https://doi.org/10.4269/ajtmh.1952.1.30openalex-snapshot
Research on Dengue during World War II
inferredcites →https://doi.org/10.4269/ajtmh.1974.23.974openalex-snapshot
Etiologies of the Experimental Dengues of Siler and Simmons
inferredcites →https://doi.org/10.4269/ajtmh.2007.77.910openalex-snapshot
Analysis of Repeat Hospital Admissions for Dengue to Estimate the Frequency of Third or Fourth Dengue Infections Resulting in Admissions and Dengue Hemorrhagic Fever, and Serotype Sequences
inferredcites →https://doi.org/10.4269/ajtmh.2009.80.302openalex-snapshot
Evaluation of Interferences between Dengue Vaccine Serotypes in a Monkey Model

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4141045openalex-extracted
In Vitro Neutralisation of Zika Virus by an Engineered Protein Targeting the Viral Envelope Fusion Loop
inferred← citeshttps://doi.org/10.1007/82_2025_307openalex-snapshot
Diagnostic Techniques for Dengue Virus
inferred← citeshttps://doi.org/10.1007/978-981-10-8727-1_5openalex-snapshot
The Molecular Specificity of the Human Antibody Response to Dengue Virus Infections
inferred← citeshttps://doi.org/10.1007/s00253-023-12817-5openalex-snapshot
Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain
inferred← citeshttps://doi.org/10.1016/j.antiviral.2016.01.002openalex-snapshot
The development of therapeutic antibodies against dengue virus
inferred← citeshttps://doi.org/10.1016/j.antiviral.2024.105941openalex-snapshot
Influence of adjuvant type and route of administration on the immunogenicity of Leishmania-derived tick-borne encephalitis virus-like particles – A recombinant vaccine candidate
inferred← citeshttps://doi.org/10.1016/j.biologicals.2018.10.003openalex-snapshot
Human single-chain variable fragment antibody expressed in E. coli with optimal in vitro cross-neutralizing and no enhancing activity
inferred← citeshttps://doi.org/10.1016/j.celrep.2022.110930openalex-snapshot
Vaccine-induced antibodies to contemporary strains of dengue virus type 4 show a mechanistic correlate of protective immunity
inferred← citeshttps://doi.org/10.1016/j.chom.2016.04.013openalex-snapshot
Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody
inferred← citeshttps://doi.org/10.1016/j.coviro.2020.08.006openalex-snapshot
Protective and enhancing interactions among dengue viruses 1-4 and Zika virus
inferred← citeshttps://doi.org/10.1016/j.coviro.2020.09.005openalex-snapshot
Historical discourse on the development of the live attenuated tetravalent dengue vaccine candidate TV003/TV005
inferred← citeshttps://doi.org/10.1016/j.immuni.2022.04.010openalex-snapshot
Inducing broad-based immunity against viruses with pandemic potential
inferred← citeshttps://doi.org/10.1016/j.intimp.2025.114032openalex-snapshot
HeterologousPrime-Boost immunizationwithAdenoviral vector and recombinant subunit vaccines strategies against dengue virus type2
inferred← citeshttps://doi.org/10.1016/j.isci.2022.104764openalex-snapshot
Infection order outweighs the role of CD4+ T cells in tertiary flavivirus exposure
inferred← citeshttps://doi.org/10.1016/j.nurpra.2014.10.019openalex-snapshot
Dengue Virus: Another Type of Immigrant
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.04.017openalex-snapshot
Consultation on dengue vaccines: Progress in understanding protection, 26–28 June 2013, Rockville, Maryland
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.09.108openalex-snapshot
Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.04.065openalex-snapshot
Characterization of recombinant yellow fever-dengue vaccine viruses with human monoclonal antibodies targeting key conformational epitopes
inferred← citeshttps://doi.org/10.1016/j.vaccine.2025.127219openalex-snapshot
A novel immunogen comprising a bc loop and mutant fusion loop epitopes generates potent neutralization and protective abilities against flaviviruses without risk of disease enhancement
inferred← citeshttps://doi.org/10.1016/j.virol.2022.09.007openalex-snapshot
A human monoclonal antibody to neutralize all four serotypes of dengue virus derived from patients at the convalescent phase of infection
inferred← citeshttps://doi.org/10.1016/j.ymthe.2017.06.020openalex-snapshot
Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys
inferred← citeshttps://doi.org/10.1038/emi.2017.79openalex-snapshot
Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III
inferred← citeshttps://doi.org/10.1038/ni.3058openalex-snapshot
A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
inferred← citeshttps://doi.org/10.1038/ni.3081openalex-snapshot
Broad and strong: the ultimate antibody to dengue virus
inferred← citeshttps://doi.org/10.1038/nrmicro.2015.2openalex-snapshot
Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
inferred← citeshttps://doi.org/10.1038/s41467-024-49461-0openalex-snapshot
Precision arbovirus serology with a pan-arbovirus peptidome
inferred← citeshttps://doi.org/10.1038/s41467-025-64210-7openalex-snapshot
Ultrapotent human antibodies lock E protein dimers central region of diverse DENV3 morphological variants
inferred← citeshttps://doi.org/10.1038/s41467-026-74406-0openalex-snapshot
Longitudinal antibody profiling after dengue reveals distinct dynamics by antibody specificity over 18 months
inferred← citeshttps://doi.org/10.1038/s41541-016-0003-3openalex-snapshot
A potent neutralizing antibody with therapeutic potential against all four serotypes of dengue virus
inferred← citeshttps://doi.org/10.1038/s41590-021-00966-6openalex-snapshot
Protective Zika vaccines engineered to eliminate enhancement of dengue infection via immunodominance switch
inferred← citeshttps://doi.org/10.1038/s41598-021-92403-9openalex-snapshot
An affinity-matured human monoclonal antibody targeting fusion loop epitope of dengue virus with in vivo therapeutic potency
inferred← citeshttps://doi.org/10.1038/s42003-023-05661-wopenalex-snapshot
Antibodies from dengue patients with prior exposure to Japanese encephalitis virus are broadly neutralizing against Zika virus
inferred← citeshttps://doi.org/10.1038/srep28768openalex-snapshot
How antibodies alter the cell entry pathway of dengue virus particles in macrophages
inferred← citeshttps://doi.org/10.1038/srep29201openalex-snapshot
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral Responses
inferred← citeshttps://doi.org/10.1039/d2me00170eopenalex-snapshot
In vitro neutralisation of Zika virus by an engineered protein targeting the viral envelope fusion loop
inferred← citeshttps://doi.org/10.1080/07391102.2024.2311350openalex-snapshot
Structure-based evaluation of the envelope domain III–nonstructural protein 1 (EDIII-NS1) fusion as a dengue virus vaccine candidate
inferred← citeshttps://doi.org/10.1080/21645515.2019.1643676openalex-snapshot
Does structurally-mature dengue virion matter in vaccine preparation in post-Dengvaxia era?
inferred← citeshttps://doi.org/10.1080/21645515.2020.1748989openalex-snapshot
A quantitative luciferase-based cell–cell fusion assay to measure four-serotype dengue virus E protein-triggered membrane fusion
inferred← citeshttps://doi.org/10.1080/22221751.2020.1797540openalex-snapshot
Enzyme-linked immunosorbent assays using virus-like particles containing mutations of conserved residues on envelope protein can distinguish three flavivirus infections
inferred← citeshttps://doi.org/10.1089/vim.2023.0153openalex-snapshot
Characterization of Two Highly Specific Monoclonal Antibodies Targeting the Glycan Loop of the Zika Virus Envelope Protein
inferred← citeshttps://doi.org/10.1093/infdis/jiaa346openalex-snapshot
Characterization of the Type-Specific and Cross-Reactive B-Cell Responses Elicited by a Live-Attenuated Tetravalent Dengue Vaccine
inferred← citeshttps://doi.org/10.1093/infdis/jiab064openalex-snapshot
Development of a Novel Assay to Assess the Avidity of Dengue Virus-Specific Antibodies Elicited in Response to a Tetravalent Dengue Vaccine
inferred← citeshttps://doi.org/10.1093/infdis/jiab342openalex-snapshot
Analysis of Neutralizing Antibodies as a Correlate of Instantaneous Risk of Hospitalized Dengue in Placebo Recipients of Dengue Vaccine Efficacy Trials
inferred← citeshttps://doi.org/10.1093/infdis/jiaf171openalex-snapshot
Anti-Dengue Virus Antibody Avidity Correlates With Protection Against Symptomatic Dengue Virus Infection
inferred← citeshttps://doi.org/10.1093/infdis/jiw297openalex-snapshot
Tetravalent Dengue Vaccine Reduces Symptomatic and Asymptomatic Dengue Virus Infections in Healthy Children and Adolescents Aged 2–16 Years in Asia and Latin America
inferred← citeshttps://doi.org/10.1101/2024.04.30.24306574openalex-snapshot
Envelope-dimer epitope-like broadly protective antibodies against dengue in children following natural infection and vaccination
inferred← citeshttps://doi.org/10.1101/275685openalex-snapshot
A dengue monovalent vaccine with novel structure provides cross-protection against four serotypes of dengue virus
inferred← citeshttps://doi.org/10.1101/351700openalex-snapshot
An epitope-resurfaced virus-like particle can induce broad neutralizing antibody against four serotypes of dengue virus
inferred← citeshttps://doi.org/10.1101/cshperspect.a029371openalex-snapshot
Which Dengue Vaccine Approach Is the Most Promising, and Should We Be Concerned about Enhanced Disease after Vaccination?
inferred← citeshttps://doi.org/10.1126/scitranslmed.adq0571openalex-snapshot
Protective envelope dimer epitope–like antibodies are elicited against dengue virus in children after infection and vaccination
inferred← citeshttps://doi.org/10.1128/jvi.00273-15openalex-snapshot
Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies
inferred← citeshttps://doi.org/10.1128/jvi.00556-18openalex-snapshot
Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine
inferred← citeshttps://doi.org/10.1128/jvi.00810-14openalex-snapshot
Virus-Like Particle Secretion and Genotype-Dependent Immunogenicity of Dengue Virus Serotype 2 DNA Vaccine
inferred← citeshttps://doi.org/10.1128/jvi.00867-17openalex-snapshot
Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine
inferred← citeshttps://doi.org/10.1128/jvi.01773-23openalex-snapshot
Epitope(s) involving amino acids of the fusion loop of Japanese encephalitis virus envelope protein is(are) important to elicit protective immunity
inferred← citeshttps://doi.org/10.1128/jvi.02086-14openalex-snapshot
Variation of the Specificity of the Human Antibody Responses after Tick-Borne Encephalitis Virus Infection and Vaccination
inferred← citeshttps://doi.org/10.1128/jvi.03203-15openalex-snapshot
B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts
inferred← citeshttps://doi.org/10.1128/mbio.00755-18openalex-snapshot
T Cell Responses to Nonstructural Protein 3 Distinguish Infections by Dengue and Zika Viruses
inferred← citeshttps://doi.org/10.1128/mbio.00818-23openalex-snapshot
Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
inferred← citeshttps://doi.org/10.1128/mbio.00873-13openalex-snapshot
The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
inferred← citeshttps://doi.org/10.1128/mmbr.00078-20openalex-snapshot
Subdominance in Antibody Responses: Implications for Vaccine Development
inferred← citeshttps://doi.org/10.1128/spectrum.00918-23openalex-snapshot
Blockade-of-Binding Activities toward Envelope-Associated, Type-Specific Epitopes as a Correlative Marker for Dengue Virus-Neutralizing Antibody
inferred← citeshttps://doi.org/10.1146/annurev-immunol-042617-053142openalex-snapshot
Immune Response to Dengue and Zika
inferred← citeshttps://doi.org/10.11606/d.42.2017.tde-13072017-151634openalex-snapshot
Avaliação de formulações vacinais anti-dengue administradas pela via transcutânea visando à geração de anticorpos neutralizantes.
inferred← citeshttps://doi.org/10.11606/t.42.2019.tde-06022024-185142openalex-snapshot
Avaliação da resposta policlonal e produção de anticorpos monoclonais a partir de linfócitos B isolados de pacientes infectados pelo vírus da Dengue.
inferred← citeshttps://doi.org/10.1172/jci147066openalex-snapshot
Dengue vaccine breakthrough infections reveal properties of neutralizing antibodies linked to protection
inferred← citeshttps://doi.org/10.1186/1471-2334-14-246openalex-snapshot
Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop
inferred← citeshttps://doi.org/10.1186/s41182-016-0004-yopenalex-snapshot
Human antibody response to dengue virus: implications for dengue vaccine design
inferred← citeshttps://doi.org/10.12688/f1000research.6233.1openalex-snapshot
Recent advances in understanding dengue
inferred← citeshttps://doi.org/10.1371/journal.pntd.0003749openalex-snapshot
The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
inferred← citeshttps://doi.org/10.1371/journal.pntd.0005554openalex-snapshot
Dissecting the human serum antibody response to secondary dengue virus infections
inferred← citeshttps://doi.org/10.1371/journal.pntd.0006209openalex-snapshot
Neutralization of antibody-enhanced dengue infection by VIS513, a pan serotype reactive monoclonal antibody targeting domain III of the dengue E protein
inferred← citeshttps://doi.org/10.1371/journal.pntd.0009258openalex-snapshot
Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)
inferred← citeshttps://doi.org/10.1371/journal.ppat.1009331openalex-snapshot
Antibody affinity versus dengue morphology influences neutralization
inferred← citeshttps://doi.org/10.1371/journal.ppat.1011722openalex-snapshot
Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses
inferred← citeshttps://doi.org/10.1586/14760584.2016.1121814openalex-snapshot
Paradoxical role of antibodies in dengue virus infections: considerations for prophylactic vaccine development
inferred← citeshttps://doi.org/10.21203/rs.3.rs-1220220/v1openalex-snapshot
Infection order outweighs the role of CD4+ T cells in tertiary flavivirus infection
inferred← citeshttps://doi.org/10.2174/0929867324666170508110222openalex-snapshot
Defensive and Offensive Cross-Reactive Antibodies Elicited by Pathogens: The Good, the Bad and the Ugly
inferred← citeshttps://doi.org/10.2174/0929867325666180629124709openalex-snapshot
Latest Updates in Dengue Fever Therapeutics: Natural, Marine and Synthetic Drugs
inferred← citeshttps://doi.org/10.2217/fvl.15.13openalex-snapshot
Can Reductions in the Cross-Reactivity of Flavivirus Structural Proteins Lead to Improved Safety and Immunogenicity of Tetravalent Dengue Vaccine?
inferred← citeshttps://doi.org/10.3389/fcimb.2026.1882915openalex-snapshot
Longitudinal assessment of MPXV-specific IgG avidity in patients with Mpox infection
inferred← citeshttps://doi.org/10.3389/fimmu.2019.02260openalex-snapshot
Seeking Flavivirus Cross-Protective Immunity
inferred← citeshttps://doi.org/10.3389/fimmu.2020.00020openalex-snapshot
Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting Cells in Humans Is Associated With the Activation of the Tryptophan Metabolism
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1560851openalex-snapshot
Factors determining the outcomes of immune imprinting after repeated orthoflavivirus infections
inferred← citeshttps://doi.org/10.3389/fimmu.2025.1626823openalex-snapshot
Mature dengue virus particles inactivated by a non-ionic detergent retain quaternary neutralizing epitopes and induce potent neutralizing antibodies
inferred← citeshttps://doi.org/10.3389/fmicb.2017.01372openalex-snapshot
Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development
inferred← citeshttps://doi.org/10.3389/fmicb.2018.01214openalex-snapshot
Potent Neutralization Ability of a Human Monoclonal Antibody Against Serotype 1 Dengue Virus
inferred← citeshttps://doi.org/10.3389/fmicb.2024.1472824openalex-snapshot
An engineered Japanese encephalitis virus mRNA-lipid nanoparticle immunization induces protective immunity in mice
inferred← citeshttps://doi.org/10.3390/pathogens9060470openalex-snapshot
Adaptive Immunity to Dengue Virus: Slippery Slope or Solid Ground for Rational Vaccine Design?
inferred← citeshttps://doi.org/10.3390/v12050514openalex-snapshot
Transcutaneous Administration of Dengue Vaccines
inferred← citeshttps://doi.org/10.3390/v13081446openalex-snapshot
Morphological Diversity and Dynamics of Dengue Virus Affecting Antigenicity
inferred← citeshttps://doi.org/10.3390/vaccines8020174openalex-snapshot
When Can One Vaccinate with a Live Vaccine after Wild-Type Dengue Infection?
inferred← citeshttps://doi.org/10.4149/av_2016_03_249openalex-snapshot
Relative contribution of dengue prM- and E-specific polyclonal antibodies to neutralization and enhancement
inferred← citeshttps://doi.org/10.64898/2026.01.30.702935openalex-snapshot
Dengue virus-specific memory B cell subsets differ as a function of infection history
inferred← citeshttps://doi.org/10.64898/2026.09.15.26363039openalex-snapshot
Signatures of the neutralizing dengue virus-reactive memory B cell repertoire identified by multiplexed envelope dimer probes
inferred← citeshttps://doi.org/10.70675/84773006z54bez4906zb40dzc0f24aaeb05aopenalex-snapshot
Contribution à la caractérisation moléculaire et cellulaire des chimères YF-17D / Dengue dans le cadre du développement préclinique du vaccin Dengvaxia®
inferred← citeshttps://doi.org/10.7554/elife.38970openalex-snapshot
Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody
inferred← citeshttps://doi.org/10.7554/elife.52384openalex-snapshot
Broadly neutralizing human antibodies against dengue virus identified by single B cell transcriptomics
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.